APOTHEEK AERNOUTS: what changed
APOTHEEK AERNOUTS
Largest movements
- Cash +€74,548
up €74,548 (+14.4%), from €519,267 to €593,815
mainly Trade debts (+€56,746) and Net result for the year (+€53,096)
- Tangible fixed assets -€40,582
down €40,582 (-37.7%), from €107,534 to €66,952
of which Furniture and vehicles: -€20,995
- Stocks and contracts +€31,732
up €31,732 (+17.0%), from €186,720 to €218,452
- Receivables within one year +€18,999
up €18,999 (+19.7%), from €96,291 to €115,290
of which Trade receivables: +€13,359
- Trade debts +€56,746
up €56,746 (+34.3%), from €165,352 to €222,098
- Profit (loss) carried forward +€50,759
up €50,759 (+8.0%), from €634,224 to €684,982
- Current portion of long-term debt -€19,211
down €19,211 (-100%), from €19,211 to €0
- Staff costs -€7,784
down €7,784 (-6.6%), from €118,609 to €110,825
- Gross operating margin -€5,742
down €5,742 (-2.4%), from €238,972 to €233,229
- Financial income -€3,394
down €3,394 (-77.2%), from €4,398 to €1,004
Change in the result, 2025 to 2026
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2025 and 2026 balance sheets and the 2026 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €918,092 | €1,003,147 | +€85,055 | +9.3% |
| Fixed assets | 21/28 | €108,337 | €67,755 | -€40,582 | -37.5% |
| Tangible fixed assets | 22/27 | €107,534 | €66,952 | -€40,582 | -37.7% |
| Land and buildings | 22 | €17,001 | €0 | -€17,001 | -100% |
| Plant, machinery and equipment | 23 | €18,939 | €16,353 | -€2,587 | -13.7% |
| Furniture and vehicles | 24 | €71,594 | €50,599 | -€20,995 | -29.3% |
| Financial fixed assets | 28 | €803 | €803 | = | 0.0% |
| Current assets | 29/58 | €809,755 | €935,392 | +€125,637 | +15.5% |
| Stocks and contracts in progress | 3 | €186,720 | €218,452 | +€31,732 | +17.0% |
| Stocks | 30/36 | €186,720 | €218,452 | +€31,732 | +17.0% |
| Amounts receivable within one year | 40/41 | €96,291 | €115,290 | +€18,999 | +19.7% |
| Trade receivables | 40 | €91,835 | €105,194 | +€13,359 | +14.5% |
| Other amounts receivable | 41 | €4,456 | €10,095 | +€5,640 | +127% |
| Current investments | 50/53 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €519,267 | €593,815 | +€74,548 | +14.4% |
| Deferred charges and accrued income | 490/1 | €7,478 | €7,835 | +€358 | +4.8% |
| Total equity and liabilities | 10/49 | €918,092 | €1,003,147 | +€85,055 | +9.3% |
| Equity | 10/15 | €654,675 | €705,434 | +€50,759 | +7.8% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Reserves | 13 | €1,859 | €1,859 | = | 0.0% |
| Distributable reserves | 133 | €1,859 | €1,859 | = | 0.0% |
| Profit (loss) carried forward | 14 | €634,224 | €684,982 | +€50,759 | +8.0% |
| Amounts payable | 17/49 | €263,417 | €297,714 | +€34,296 | +13.0% |
| Amounts payable after more than one year | 17 | €0 | - | = | |
| Financial debts | 170/4 | €0 | - | = | |
| Amounts payable within one year | 42/48 | €259,464 | €294,143 | +€34,679 | +13.4% |
| Current portion of amounts payable after more than one year | 42 | €19,211 | €0 | -€19,211 | -100% |
| Trade debts | 44 | €165,352 | €222,098 | +€56,746 | +34.3% |
| Suppliers | 440/4 | €165,352 | €222,098 | +€56,746 | +34.3% |
| Taxes, remuneration and social security | 45 | €24,013 | €18,972 | -€5,041 | -21.0% |
| Taxes | 450/3 | €1,248 | €1,136 | -€112 | -9.0% |
| Remuneration and social security | 454/9 | €22,765 | €17,836 | -€4,929 | -21.7% |
| Other amounts payable | 47/48 | €50,889 | €53,074 | +€2,185 | +4.3% |
| Accrued charges and deferred income | 492/3 | €3,953 | €3,571 | -€383 | -9.7% |
| Remuneration, social security and pensions | 62 | €118,609 | €110,825 | -€7,784 | -6.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €42,509 | €41,854 | -€654 | -1.5% |
| Other operating charges | 640/8 | €344 | €393 | +€49 | +14.3% |
| Gross operating margin | 9900 | €238,972 | €233,229 | -€5,742 | -2.4% |
| Operating profit (loss) | 9901 | €77,509 | €80,157 | +€2,647 | +3.4% |
| Financial income | 75/76B | €4,398 | €1,004 | -€3,394 | -77.2% |
| Recurring financial income | 75 | €4,398 | €1,004 | -€3,394 | -77.2% |
| Financial charges | 65/66B | €7,133 | €8,898 | +€1,765 | +24.7% |
| Recurring financial charges | 65 | €7,133 | €8,898 | +€1,765 | +24.7% |
| Profit (loss) for the period before taxes | 9903 | €74,773 | €72,262 | -€2,511 | -3.4% |
| Income taxes | 67/77 | €19,921 | €19,167 | -€754 | -3.8% |
| Profit (loss) for the period | 9904 | €54,852 | €53,096 | -€1,757 | -3.2% |
| Profit (loss) for the period to be appropriated | 9905 | €54,852 | €53,096 | -€1,757 | -3.2% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.